creatine has been researched along with Cardiac Diseases in 24 studies
Excerpt | Relevance | Reference |
---|---|---|
"Age is a known susceptibility factor for the cardiotoxicity of several anticancer drugs, including mitoxantrone (MTX)." | 7.81 | The age factor for mitoxantrone's cardiotoxicity: multiple doses render the adult mouse heart more susceptible to injury. ( Bastos, Mde L; Carvalho, F; Costa, VM; Dores-Sousa, JL; Duarte, JA; Seabra, V, 2015) |
"Age is a known susceptibility factor for the cardiotoxicity of several anticancer drugs, including mitoxantrone (MTX)." | 3.81 | The age factor for mitoxantrone's cardiotoxicity: multiple doses render the adult mouse heart more susceptible to injury. ( Bastos, Mde L; Carvalho, F; Costa, VM; Dores-Sousa, JL; Duarte, JA; Seabra, V, 2015) |
"Creatine is a dietary supplement purported to improve exercise performance and increase fat-free mass." | 2.41 | Clinical pharmacology of the dietary supplement creatine monohydrate. ( Brazeau, GA; Persky, AM, 2001) |
" Dosing of these agents should be adjusted to take such factors into account to minimize the incidence of proarrhythmia." | 2.41 | Importance of QT interval determination and renal function assessment during antiarrhythmic drug therapy. ( Appel, G; Reiffel, JA, 2001) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 14 (58.33) | 18.7374 |
1990's | 2 (8.33) | 18.2507 |
2000's | 6 (25.00) | 29.6817 |
2010's | 2 (8.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dores-Sousa, JL | 1 |
Duarte, JA | 1 |
Seabra, V | 1 |
Bastos, Mde L | 1 |
Carvalho, F | 1 |
Costa, VM | 1 |
MESSINA, R | 1 |
Mikkelsen, MM | 1 |
Andersen, NH | 1 |
Christensen, TD | 1 |
Hansen, TK | 1 |
Eiskjaer, H | 1 |
Mogensen, CE | 1 |
Hjortdal, VE | 1 |
Johnsen, SP | 1 |
Faller, KM | 1 |
Lygate, CA | 1 |
Neubauer, S | 1 |
Schneider, JE | 1 |
CAPONNETTO, S | 1 |
MARTINI, U | 1 |
LAMPERI, S | 1 |
MIELER, W | 1 |
RAGAN, C | 1 |
BRISCOE, AM | 1 |
GRAYBIEL, A | 1 |
PATTERSON, CA | 1 |
De Hert, SG | 1 |
Van der Linden, PJ | 1 |
Cromheecke, S | 1 |
Meeus, R | 1 |
Nelis, A | 1 |
Van Reeth, V | 1 |
ten Broecke, PW | 1 |
De Blier, IG | 1 |
Stockman, BA | 1 |
Rodrigus, IE | 1 |
Nakae, I | 2 |
Mitsunami, K | 2 |
Matsuo, S | 2 |
Inubushi, T | 2 |
Morikawa, S | 2 |
Tsutamoto, T | 1 |
Koh, T | 2 |
Horie, M | 2 |
Matsumoto, T | 1 |
Lee, TH | 1 |
Marcantonio, ER | 1 |
Mangione, CM | 1 |
Thomas, EJ | 1 |
Polanczyk, CA | 1 |
Cook, EF | 1 |
Sugarbaker, DJ | 1 |
Donaldson, MC | 1 |
Poss, R | 1 |
Ho, KK | 1 |
Ludwig, LE | 1 |
Pedan, A | 1 |
Goldman, L | 1 |
Shen, W | 1 |
Asai, K | 1 |
Uechi, M | 1 |
Mathier, MA | 1 |
Shannon, RP | 1 |
Vatner, SF | 1 |
Ingwall, JS | 1 |
Persky, AM | 1 |
Brazeau, GA | 1 |
Reiffel, JA | 1 |
Appel, G | 1 |
Myers, BD | 1 |
Garas, Z | 1 |
Kanyár, B | 1 |
Komor, K | 1 |
Rowland, LP | 1 |
Fontana, A | 1 |
Lusena, S | 1 |
Mori, K | 1 |
Sasaki, M | 1 |
Takahara, K | 1 |
Natelson, S | 1 |
Tomlinson, BE | 1 |
Walton, JN | 1 |
Irving, D | 1 |
Banchieri, GC | 1 |
Fine, W | 1 |
Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
---|---|---|---|---|---|---|---|
Utility of Pulmonary Echography for Evaluation of Patients Undergoing Orthopedic Surgery for Femur Fracture[NCT04074876] | 877 participants (Actual) | Observational | 2019-12-01 | Active, not recruiting | |||
Assessment of the Feasibility of Ultrasound Guided Serratus Plane Block Associated With Sedation as Anesthetic Technique in Axillary Dissection[NCT03740815] | 15 participants (Actual) | Interventional | 2018-09-25 | Completed | |||
The Application of Goal-directed Therapy With the Combination of Stroke Volume Variation and Cardiac Index as the Primary Judgment in Non-severe Patients Underwent Gastrointestinal Tumor Surgery[NCT02841046] | 50 participants (Actual) | Interventional | 2016-07-27 | Completed | |||
Pulse Wave Velocity as a Predictor for Postoperative Cardiovascular Events[NCT03223441] | 543 participants (Actual) | Observational | 2015-06-30 | Completed | |||
MET: REevaluation for Perioperative cArdIac Risk (MET-REPAIR): a Prospective, Multi-centre Cohort Observational Study- Presepsin (sCD14-ST) for Perioperative Risk Prediction Nested Cohort Study[NCT03489486] | 1,695 participants (Anticipated) | Observational | 2018-06-15 | Recruiting | |||
MET: REevaluation for Perioperative cArdIac Risk (MET-REPAIR) Observational Multicentre Study[NCT03016936] | 15,000 participants (Actual) | Observational | 2017-08-01 | Completed | |||
Randomized Conversion of Calcineurin-Inhibitors(Tacrolimus to Sirolimus),6-24 Months Post Transplant Prednisone-Free Immunosuppression Regimen: Impact of Incidence of Acute Cellular Rejection,Renal Allograft Function & Lymphocytes Function[NCT00866879] | Phase 4 | 275 participants (Actual) | Interventional | 2007-06-30 | Completed | ||
Genetic Predisposition of Chronic Nephrotoxicity From Calcineurin Inhibitors in Liver Transplant Recipients, Potential Correlation With Urinary Biomarkers[NCT00857844] | 207 participants (Actual) | Observational | 2007-07-31 | Completed | |||
[information is prepared from clinicaltrials.gov, extracted Sep-2024] |
record the number of days needed for anal exsufflation in non-severe patients after gastrointestinal tumor surgery (NCT02841046)
Timeframe: up to 8 weeks
Intervention | days (Mean) |
---|---|
Group Cardiac Index | 3.8 |
Group Stroke Volume Variation | 2.7 |
The primary purpose of this research study is to evaluate whether the use of mycophenolate mofetil/Cellcept ® and either tacrolimus/Prograf ® (Group #1) or mycophenolate mofetil/Cellcept ® and sirolimus/Rapamune® (Group #2) impacts the incidence of acute cellular rejection in post-kidney transplant patients. This study will examine whether switching from tacrolimus to sirolimus will better preserve long-term kidney function. (NCT00866879)
Timeframe: Assessed at 6 Months, 12 Months, 24 Months, months 24 reported
Intervention | Participants (Count of Participants) |
---|---|
Control | 7 |
Transition to Sirolimus Group | 31 |
"Specifically we reported here the percentage of regulatory T cells that were present in the two groups at 24 months post randomization.~With peripheral leukocytes taken at baseline (first visit) prior to randomization and at 6, 12 and 24 Months post-randomization, researchers will also review possible modifications of lymphocytes function and of the lymphocytes subpopulations that might have occurred as a consequence of the switch from tacrolimus to sirolimus (randomization)." (NCT00866879)
Timeframe: Assessed at 6 Months, 12 Months, 24 Months, months 24 reported
Intervention | % of Treg Cells (Mean) |
---|---|
Control | 75 |
Transition to Sirolimus Group | 98 |
Evaluate whether CI conversion (tacrolimus→sirolimus) contributes positively or negatively on the renal allograft function calculated with e-GFR and proteinuria (NCT00866879)
Timeframe: Assessed at 6 Months, 12 Months, 24 Months, months 24 reported
Intervention | mL/min (Mean) |
---|---|
Control | 57.6 |
Transition to Sirolimus Group | 58.4 |
In addition to monitoring renal allograft function, evaluation will be conducted on the incidence of acute rejection, patient and graft survival, the impact of CI conversion on the lipid profile, the incidence of hypertension, malignancies, opportunistic infections and post-transplant DM (de novo diabetes mellitus). (NCT00866879)
Timeframe: Assessed at 6 Months, 12 Months, 24 Months, months 24 reported
Intervention | number of incidents (Number) | |||||||
---|---|---|---|---|---|---|---|---|
Infections | Malignancies | Proteinura | Hyperlipidemia | NODAT | BK viremia | BK nephropathy | Neutropenia | |
Control | 33 | 4 | 12 | 9 | 3 | 15 | 1 | 22 |
Transition to Sirolimus Group | 83 | 9 | 61 | 19 | 2 | 28 | 5 | 35 |
This study also reviews the impact of the immunosuppressive medications on patient and graft survival. (NCT00866879)
Timeframe: Assessed at 6 Months, 12 Months, 24 Months, months 24 reported
Intervention | number of incidents (Number) | |
---|---|---|
Kidney transplant loss | Patient death | |
Control | 4 | 3 |
Transition to Sirolimus Group | 12 | 10 |
5 reviews available for creatine and Cardiac Diseases
Article | Year |
---|---|
(1)H-MR spectroscopy for analysis of cardiac lipid and creatine metabolism.
Topics: Animals; Creatine; Heart Diseases; Humans; Lipid Metabolism; Lipids; Magnetic Resonance Spectroscopy | 2013 |
Clinical pharmacology of the dietary supplement creatine monohydrate.
Topics: Animals; Area Under Curve; Creatine; Dietary Supplements; Energy Metabolism; Heart Diseases; Humans; | 2001 |
Importance of QT interval determination and renal function assessment during antiarrhythmic drug therapy.
Topics: Age Factors; Anti-Arrhythmia Agents; Creatine; Dose-Response Relationship, Drug; Heart Diseases; Hum | 2001 |
Cyclosporine nephrotoxicity.
Topics: Acute Kidney Injury; Adult; Azathioprine; Creatine; Cyclosporins; Glomerular Filtration Rate; Glomer | 1986 |
Cyclosporine nephrotoxicity.
Topics: Acute Kidney Injury; Adult; Azathioprine; Creatine; Cyclosporins; Glomerular Filtration Rate; Glomer | 1986 |
Cyclosporine nephrotoxicity.
Topics: Acute Kidney Injury; Adult; Azathioprine; Creatine; Cyclosporins; Glomerular Filtration Rate; Glomer | 1986 |
Cyclosporine nephrotoxicity.
Topics: Acute Kidney Injury; Adult; Azathioprine; Creatine; Cyclosporins; Glomerular Filtration Rate; Glomer | 1986 |
Muscular dystrophies.
Topics: Alopecia; Creatine; Diagnosis, Differential; Electromyography; Eye Manifestations; Facial Paralysis; | 1972 |
1 trial available for creatine and Cardiac Diseases
Article | Year |
---|---|
Cardioprotective properties of sevoflurane in patients undergoing coronary surgery with cardiopulmonary bypass are related to the modalities of its administration.
Topics: Aged; Anesthesia, Inhalation; Anesthesia, Intravenous; Anesthetics, Inhalation; Anesthetics, Intrave | 2004 |
18 other studies available for creatine and Cardiac Diseases
Article | Year |
---|---|
The age factor for mitoxantrone's cardiotoxicity: multiple doses render the adult mouse heart more susceptible to injury.
Topics: Age Factors; Animals; Antineoplastic Agents; Aspartate Aminotransferases; Biomarkers; Body Weight; C | 2015 |
The influence of vitamin PP on the exchange of creatine and creatinine in some morbid conditions; behavior of creatine and creatinine in the heart.
Topics: Creatine; Heart Diseases; Niacinamide; Nutrition Therapy | 1948 |
Microalbuminuria and short-term prognosis in patients undergoing cardiac surgery.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albumins; Albuminuria; Atrial Fibrillation; Biomarkers; | 2009 |
[Clinical study and study of the metabolism of creatine bodies in heart patients treated with inosine].
Topics: Biomedical Research; Creatine; Creatinine; Heart; Heart Diseases; Inosine; Metabolic Diseases; Nucle | 1961 |
[CREATINE CONTENT IN THE SERUM OF NORMAL AND SICK CHILDREN].
Topics: Adolescent; Blood Chemical Analysis; Blood Donors; Child; Communicable Diseases; Creatine; Creatinin | 1964 |
EFFECT OF EXERCISE ON THE METABOLISM OF 40-CALCIUM AND OF 47-CALCIUM IN MAN.
Topics: Arthritis; Arthritis, Rheumatoid; Calcium; Calcium Isotopes; Calcium, Dietary; Creatine; Creatinine; | 1964 |
Use of betaine and glycocyamine in the treatment of patients with heart disease: preliminary report.
Topics: Betaine; Cardiovascular Diseases; Creatine; Glycine; Heart Diseases; Humans | 1951 |
Myocardial creatine concentration in various nonischemic heart diseases assessed by 1H magnetic resonance spectroscopy.
Topics: Adult; Aged; Creatine; Female; Heart Diseases; Humans; Magnetic Resonance Imaging; Magnetic Resonanc | 2005 |
Assessment of myocardial creatine concentration in dysfunctional human heart by proton magnetic resonance spectroscopy.
Topics: Creatine; Female; Heart Diseases; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Myocar | 2004 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery.
Topics: Aged; Cerebrovascular Disorders; Cohort Studies; Creatine; Female; Heart Diseases; Humans; Incidence | 1999 |
Progressive loss of myocardial ATP due to a loss of total purines during the development of heart failure in dogs: a compensatory role for the parallel loss of creatine.
Topics: Adenosine Triphosphate; Animals; Creatine; Dog Diseases; Dogs; Heart; Heart Diseases; Hemodynamics; | 1999 |
[51Cr-EDTA and endogenous creatine clearance studies].
Topics: Cardiovascular Diseases; Chromium Radioisotopes; Creatine; Diabetes Mellitus; Diagnostic Errors; Ede | 1974 |
[Clinical study on the effects of creatinol-O-phosphate in patients with heart diseases under digitalis treatment].
Topics: Aged; Alcohols; Arrhythmias, Cardiac; Coronary Disease; Creatine; Drug Synergism; Drug Tolerance; Fe | 1972 |
[Effect of exercise on myocardial metabolism of inorganic phosphorus and creatine in patients with heart diseases].
Topics: Adult; Asthenia; Coronary Disease; Coronary Vessels; Creatine; Female; Heart Diseases; Heart Valve D | 1972 |
Urinary guanidinoacetate-guanidinosuccinate ratio: an indicator of kidney dysfunction.
Topics: Acetates; Adult; Aged; Blood Urea Nitrogen; Body Weight; Chromatography, Ion Exchange; Creatine; Cre | 1973 |
Spinal cord limb motor neurones in muscular dystrophy.
Topics: Adolescent; Adult; Autoantibodies; Autopsy; Creatine; Diagnostic Errors; Electrocardiography; Electr | 1974 |
[Creatinuria and creatininuria in connection with age, sex and different pathologic conditions].
Topics: Adult; Age Factors; Aged; Cardiovascular Diseases; Creatine; Creatinine; Female; Heart Diseases; Hum | 1968 |
Some common factors in the causation of postural hypotension.
Topics: 17-Ketosteroids; Aged; Arrhythmias, Cardiac; Asthenia; Blood Pressure; Blood Volume; Chlorides; Crea | 1969 |